associated with 17 other trademarks
Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based t...

Words that describe this trademark:

conducting clinical trials  therapies  conjugate  based  fragment 

Serial Number:

97073021

Mark:

Status:

Registered

Status Date:

10-24-2023

Filing Date:

Registration Number:

7202810

Registration Date:

10-24-2023

Goods and Services:

Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, oncological, hepatological, ophthalmic, respiratory, central and/or peripheral neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology

Mark Description:

The mark consists of 5 parallel wavy lines on top of one another with the first line at the top measuring about half-length of the other 4 lines beneath it.

Class:

Scientific and technological services

Type of Mark:

Trademark

Published for Opposition Date:

06-28-2022

Mark Drawing Status:

Design Only

Abandon Date:

N/A

Business Name:

WILSON SONSINI GOODRICH & ROSATI

Correspondent Name:

Recent Trademark filings by this company